Considering previous reports, we hypothesized that BUB1B, CCNB1, CDC7, CDC20, and MCM3 should be novel prognostic biomarkers and promising therapeutic targets for HCC patients. This evidence concerns the gene CCNB1 and hepatocellular carcinoma.